Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Other Working Capital Changes (2020 - 2025)

Bioventus' Other Working Capital Changes history spans 6 years, with the latest figure at $673000.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 90.88% year-over-year to $673000.0; the TTM value through Dec 2025 reached $1.7 million, down 33.5%, while the annual FY2025 figure was $1.7 million, 33.5% down from the prior year.
  • Other Working Capital Changes reached $673000.0 in Q4 2025 per BVS's latest filing, down from $2.3 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $16.1 million in Q4 2021 to a low of -$9.8 million in Q4 2022.
  • Average Other Working Capital Changes over 5 years is $636950.0, with a median of $204000.0 recorded in 2022.
  • Peak YoY movement for Other Working Capital Changes: surged 1205.19% in 2021, then plummeted 738.96% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at $16.1 million in 2021, then tumbled by 161.1% to -$9.8 million in 2022, then surged by 125.38% to $2.5 million in 2023, then soared by 195.79% to $7.4 million in 2024, then crashed by 90.88% to $673000.0 in 2025.
  • Per Business Quant, the three most recent readings for BVS's Other Working Capital Changes are $673000.0 (Q4 2025), $2.3 million (Q3 2025), and -$492000.0 (Q2 2025).